Windtree Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 20.29 million compared to USD 39.21 million a year ago. Basic loss per share from continuing operations was USD 94.3199 compared to USD 1,120.1391 a year ago.